If the intended use of such devices includes treatment of children or treatment of pregnant or breastfeeding women or treatment of other patient groups considered particularly vulnerable to such substances and/or materials, information on residual risks for those patient groups and, if applicable, on appropriate precautionary measures shall be given in the instructions for use.
Má áirítear san úsáid a beartaíodh d'fheistí den sórt sin cóireáil a chur ar leanaí nó ar mhná torracha nó ar mhná atá ag tabhairt cíche do leanbh nó cóireáil a chur ar ghrúpaí eile othar a mheastar a bheith an-leochaileach do na substaintí agus/nó do na hábhair sin, déanfar faisnéis maidir le rioscaí iarmharacha do na grúpaí othar sin, agus, más infheidhme, maidir le bearta iomchuí réamhchúramacha, a thabhairt sna treoracha úsáide.